近日,来自台北医学大学的研究人员在国际学术期刊cancer research上在线发表了一项最新研究进展,他们发现EGFR发生细胞核定位能够抑制肿瘤抑制因子mi R-1的表达,从而促进前列腺癌的骨转移。前列腺癌是一种发生在前列腺的上皮恶性肿瘤,也是男性泌尿生殖系统最常见的恶性肿瘤之一,前列腺癌是导致美国男性因癌症死亡的第二大杀手。根据一项数据调查显示,2014年美国有大约233,000名男性诊断为前列腺癌,占到新增癌症病例的27%。前列腺癌的发生受到很多因 Recently, researchers from Taipei Medical University released a new online study on the international academic journal cancer research. They found that nuclear localization of EGFR can inhibit the expression of tumor suppressor mi R-1 and promote bone metastasis of prostate cancer . Prostate cancer is an epithelial malignancy in the prostate and one of the most common malignancies in the male genitourinary system. Prostate cancer is the second leading killer in cancer death among American men. According to a data survey, approximately 233,000 men were diagnosed with prostate cancer in the United States in 2014, accounting for 27% of new cancer cases. Prostate cancer is affected by many causes